Feedback

Pfizer to complete development of vaccine against Omicron variant in March, - CEO

Source : 112 Ukraine

The new drug will also be used against other variants of the virus that circulate all over the world
21:16, 10 January 2022

CEO of Pfizer Albert Bourla
CNBC

Pfizer is going to complete the development of vaccine against the Omicron variant in March. CEO of Pfizer company Albert Bourla said so as quoted by CNBC.

"The vaccine will be ready in March. Now, we already launched production of first doses of the vaccine", he said.

The new vaccine will also be used against other variants of the virus that circulate all over the world.

Bourla added that so far, it remains uncertain whether the fourth vaccine dose is necessary or the third booster dose would be enough. According to him, the company is looking into this issue now. 

Related: US regulator approves use of Pfizer Covid pills

In addition, it is noted that recent studies by British scientists have shown that Pfizer and Moderna vaccines are only 10% effective in preventing the symptomatic course of Covid-19 disease after 20 weeks from the administration of the second dose. At the same time, both vaccines still protect against a severe course of the disease and death for this period.

Related: Israeli Health Ministry grants emergency approval to Pfizer’s anti-Covid pill

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more
latest news
editor's choice
video